Insiders · Profile

Roivant Sciences Ltd.

Director at Immunovant. Filing since 16 Apr 2020. CIK 0001635088

Company
Date
Role
Action
Shares
Amount
Of holding
12 Dec 2025
Director
Bought
16,666,666
$350.00M
17.2%
13 Jan 2025
Director
Bought
16,845,010
$336.90M
21.1%
2 Oct 2023
Director
Bought
1,526,316
$58.00M
1.9%
6 Oct 2022
10% owner
Bought
416,667
$2.50M
0.6%
4 Sep 2020
10% owner
Bought
380,000
$12.54M
0.8%
16 Apr 2020
10% owner
Bought
1,034,483
$15.00M
2.8%
6 decisions on file.